Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

NCT00000794 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Toxoplasmosis, Cerebral
HIV Infections

Interventions

DRUG: Sulfadiazine
DRUG: Clarithromycin
DRUG: Atovaquone
DRUG: Pyrimethamine
DRUG: Leucovorin calcium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)